An Unusual Case of Oligometastases in a Patient with Renal Cell Carcinoma: Insights from <sup>18</sup>F-FDG PET/CT
PDF
Cite
Share
Request
Interesting Image
P: 179-181
October 2024

An Unusual Case of Oligometastases in a Patient with Renal Cell Carcinoma: Insights from 18F-FDG PET/CT

Mol Imaging Radionucl Ther 2024;33(3):179-181
1. King Hussein Cancer Center (KHCC) Department of Nuclear Medicine, Amman, Jordan
2. Dubai Nuclear Medicine and Molecular Imaging Center Dubai Health Authority, Dubai, United Arab Emirates
3. King Hussein Cancer Center (KHCC) Department of Medical Oncology, Amman, Jordan
No information available.
No information available
Received Date: 02.12.2023
Accepted Date: 11.01.2024
Online Date: 07.10.2024
Publish Date: 07.10.2024
PDF
Cite
Share
Request

ABSTRACT

Renal cell carcinoma (RCC) is a significant cause of mortality worldwide. To date, many atypical metastatic sites have been observed and reported in patients with RCC. However, to the best of our knowledge, there have been no reported cases of thyroid cartilage metastasis in the context of RCC metastasis. Herein, we present the case of a 68-year-old man who developed left arm pain that led to an RCC diagnosis. First, evaluation by PAN-computed tomography (CT) denoted right kidney RCC and identified left humeral metastasis. Subsequently, 18F-fluorodeoxyglucose positron emission tomography/CT (18F-FDG PET/CT) was performed after right nephrectomy and left humeral lesion excision and fixation. Interestingly, few intramedullary hypermetabolic lesions were observed in addition to a single intensely hypermetabolic thyroid cartilage lesion indicative of oligometastases. This case underscores the importance of 18F-FDG PET/CT in the evaluation of RCC disease for baseline staging and beyond.

References

1
Gaber AM, Núñez R, Delpassand E. Cases of thyroid cartilage metastasis as abnormal findings seen in prostate cancer patients visualized by 68Ga-PSMA-11 PET/CT. Egypt J Radiol Nucl Med. 2021;52:134.
2
Mendoza H, Nosov A, Pandit-Taskar N. Molecular imaging of sarcomas with FDG PET. Skeletal Radiol. 2023;52:461-475.
3
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17-48.
4
Griffin N, Gore ME, Sohaib SA. Imaging in metastatic renal cell carcinoma. AJR Am J Roentgenol. 2007;189:360-370.
5
Sountoulides P, Metaxa L, Cindolo L. Atypical presentations and rare metastatic sites of renal cell carcinoma: a review of case reports. J Med Case Rep. 2011;5:429.
6
Tripathy S, Parida GK, Singhal A, Shamim SA, Kumar R. Thyroid Cartilage Metastases on F-18 Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: A Tale of Two Cases with a Brief Review of Literature. Indian J Nucl Med. 2019;34:220-222.
7
Gupta N, Verma R, Belho ES. Metastatic Thyroid Cartilage Lesion from Prostatic Adenocarcinoma onGa-Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography Scan: Case Series. Indian J Nucl Med. 2021;36:183-8.
8
Tupalli A, Damle NA, Thankarajan AS, Mangu BS, Kumar A, Khan D, Sagar S, Bal C. An Unusual Case of Simultaneous Cricoid and Thyroid Cartilage Metastases from Prostatic Adenocarcinoma onGa-PSMA PET/CT. Nucl Med Mol Imaging. 2020;54:61-62.
9
Usmani S, Ahmed N, Ilyas MW, Murad S, Al Kandari F. Rare Thyroid Cartilage Metastasis From Breast Cancer Visualized on 18F-NaF PET/CT. Clin Nucl Med. 2021;46:43-44.